-
SpeichernDas Eingabefeld wird
gespeichert wenn Sie das Feld
verlassen oder hier klicken.↓
Börse NYSE New York Stock ExchangeUSDISIN US5324571083-
Eli Lilly and CoBörse NYSE New York Stock ExchangeISIN US5324571083USDSymbol LLY-WD
-
Eli LillyBörse Börse StuttgartISIN XS1240751229EURSymbol LLY
-
Eli Lilly and CompanyBörse Xetra FrankfurtISIN US532457BV93EURSymbol LLY
-
ELI LILLY & COBörse Börse BerlinISIN XS1240751062EURSymbol LLY
-
ELI LILLY & COBörse Börse HamburgISIN XS2075937370EURSymbol LLY
-
ELI LILLY & COBörse Gettex System der Börse MünchenISIN US532457BS64EURSymbol LLY
-
ELI LILLY & COBörse Quotrix System der Börse DüsseldorfISIN XS1240750767EURSymbol LLY
-
ELI LILLY & COBörse Tradegate System der Deutsche Börse AG (60%)ISIN US532457BR81EURSymbol LLY
-
ELI LILLY & COBörse Börse DüsseldorfISIN US532457AZ17EURSymbol LLY
-
ELI LILLY & COBörse Börse MünchenEURSymbol LLY
-
ELI LILLY & COBörse Börse FrankfurtEURSymbol LLY
-
ISIN US5324571083 WKN: 858560Symbol LLY
-
Eli Lilly and CompanyBörse Bolsa Mexicana de Valore Mexiko-StadtISIN US532457BY33
-
Eli Lilly and CompanyBörse London Stock ExchangeISIN US532457BZ08
-
Eli Lilly and CompanyBörse BVMFISIN US532457BQ09
-
Eli Lilly and CompanyBörse Bolsa de Comercio de Buenos AiresISIN US532457BH00
-
ISIN US5324571083
Symbol LLY-WD
Währung
USD
Börse
NYSE New York Stock Exchange Zeitzone: Europe/Berlin
Firmenname
Eli Lilly and Company
Marktkapitalisierung
162.609.462.741 (+- 19%)
Die einen sagen so, die anderen so... Es gibt 3 Datenquellen:
178.584.305.664 oder 193.976.000.000 oder 115.268.082.559
Mitarbeiter
35.897 (+- 9%)
Die einen sagen so, die anderen so... Es gibt 3 Datenquellen:
35.065 oder 33.625 oder 39.000 Mitarbeiter
Anzahl Aktien
956.581.598
KGV
22.62 (+- 35%)
Die einen sagen so, die anderen so... Es gibt 2 Datenquellen:
30.54 oder 14.7
EBITDA 7.741.799.936
PEGRatio 1.1871
Buchwert 5.325
Zahlte zuletzt am 13.05.2021 eine Dividende von 0,85 USD . Seit damals wurde keine Dividende mehr ausgeschüttet Übersicht
Die Dividendenrendite
entsprach 85,67 % p. a.
beim aktuellen Kurs von 204,3 EUR +0,64%
Die letzten Quartalsergebnisse Erwarteter Gewinn je Aktie beim aktuellen Wert von 204,3 EUR +0,64%
Aktionärsstruktur der Eli Lilly and Company
Portrait der Eli Lilly Aktie
Das Unternehmen Eli Lilly and Company aus USA beschäftigt 35.897 Mitarbeiter und ist in den Bereichen Chemie & Pharma, Einzelhandel (Medikamente), Einzelhandel, Pharma tätig.
Das Unternehmen Eli Lilly and Company ist in mehr als 72 ETFs enthalten und somit ein eher allgemein bekannter Wert. Der Spitzenreiter VanEck Vectors Pharmaceutical ETF gewichtet Eli Lilly mit 5,66% im ETF.
Entdecke die 6 ETFs in denen Eli Lilly and Company am höchsten gewichtet ist Insgesamt in 72 ETFs enthalten
Dir gefallen die Informationen zu Eli Lilly?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:
Zur ING Diba
Dir gefallen die Informationen zu Eli Lilly?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und für einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, sterreich oder UK zu kaufen. Wenn du das über meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:
Zu BUX Zero
Dir gefallen die Informationen zu Eli Lilly?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:
Zur Comdirect
Dir gefallen die Informationen zu Eli Lilly?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos Aktien zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:
Zu Trade Republic
196 News & Informationen zur Eli Lilly Aktie
Type 2 Diabetes Pipeline Holds a Potential Future in Treatment Scenario.
The growing Type 2 Diabetes prevalence has increased the demand for effective drug therapies. There are different classes of emerging drugs administered…
Johnson & Johnson (JNJ) Option Traders Ready for Positive Earnings
A noticeable collection of put options remain in the open interest for JNJ and appear to be initiated as sell orders.
Flatiron Health : Real-World Data Support FDA Approval of New Dosing Regimen for ERBITUX® (cetuximab)
Approval of additional dosing regimen allows cancer patients to significantly reduce frequency of treatment visits …
Why I Believe CureVac $CVAC is a Solid Long-term Investment [Their work includes rabies vaccines, lassa/yellow fever vaccines, Respirational syncytial virus vaccine, Other infectious diseases vaccines
CureVac N.V. is a German biopharmaceutical company that develops therapies based on messenger RNA. Legally domiciled in the Netherlands and …
General Atlantic : Forms BeyondNetZero to Invest in Growth Companies Delivering Innovative Climate Solutions
General Atlantic, a leading global growth equity firm, announced today the formation of BeyondNetZero , a new venture targeting growth equity investments related to climate change. BnZ is being…
Worldwide Diabetes Devices and Drugs Industry to 2026 – Featuring Novo Nordisk, Ypsomed and Abbott Laboratories Among Others
/PRNewswire/ — The “Diabetes Devices and Drugs Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2026” report has been added to…
ProfoundBio, led by SeaGen veterans and co-located in China and Seattle, raises $55M
ProfoundBio, based in Woodinville, Wash., and Suzhou, China, has raised $55 million in a Series A funding round to advance its programs developing new anti…
10 Best Psychedelic Stocks to Buy Now
In this article, we discuss the 10 best psychedelic stocks to buy now. If you want to skip our detailed analysis of these stocks, go directly to the 5…
Global Generic Drugs Market To Reach $507.8 Billion By 2026
SAN FRANCISCO, July 14, 2021 /PRNewswire/ — A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company, today
Global Generic Drugs Market to Reach $507.8 Billion by 2026
/PRNewswire/ — A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company, today released its report titled…
New TAVALISSE® Data Analyses To Be Presented at International Society on Thrombosis and Haemostasis (ISTH) 2021 Congress
/PRNewswire/ — Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL), today announced that data from its clinical development program for TAVALISSE® (fostamatinib…
Non-opioid Pain Treatment Market Size to Grow at a CAGR of 16.8% from 2021 to 2030
The global non-opioid pain treatment market valued at USD 13,200.6 million in 2020, and it is projected to grow at a CAGR of 16.8 % during the forecast…
Non-opioid Pain Treatment Market Size to Grow at a CAGR of 16.8% from 2021 to 2030
The global non-opioid pain treatment market valued at USD 13,200.6 million in 2020, and it is projected to grow at a CAGR of 16.8 % during the forecast…
Non-opioid Pain Treatment Market Size to Grow at a CAGR of 16.8% from 2021 to 2030
The global non-opioid pain treatment market valued at USD 13,200.6 million in 2020, and it is projected to grow at a CAGR of 16.8 % during the forecast…
Non-opioid Pain Treatment Market Size to Grow at a CAGR of 16.8% from 2021 to 2030
The global non-opioid pain treatment market valued at USD 13,200.6 million in 2020, and it is projected to grow at a CAGR of 16.8 % during the forecast…
Non-opioid Pain Treatment Market Size to Grow at a CAGR of 16.8% from 2021 to 2030
The global non-opioid pain treatment market valued at USD 13,200.6 million in 2020, and it is projected to grow at a CAGR of 16.8 % during the forecast…
Non-opioid Pain Treatment Market Size to Grow at a CAGR of 16.8% from 2021 to 2030
The global non-opioid pain treatment market valued at USD 13,200.6 million in 2020, and it is projected to grow at a CAGR of 16.8 % during the forecast…
Alzheimer’s Drugs Market Report 2021-2028 | Size, Share, Growth, Trends, Competitive Landscape, Revenue, Forecast Report
Key Prominent Players Covered in the Alzheimer’s Drugs Market Research Report Are Hoffmann-La Roche Ltd, Novartis AG, Pfizer Inc., Eli Lilly and Company.,…
Global Human Growth Hormone Drugs Market to Reach $4 Billion by 2026
/PRNewswire/ — A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company, today released its report titled…
Valuation in Geriatric Medicines Market to Reach US$ 1142.8 Bn by 2027, Use in Managing Cardiovascular Diseases Spurs Growth: TMR
/PRNewswire/ — Geriatrics care has made enormous strides over the past few decades. Rapidly aging populations notably in some emerging economies and developed…
Valuation In Geriatric Medicines Market To Reach US$ 1142.8 Bn By 2027, Use In Managing Cardiovascular Diseases Spurs Growth: TMR
ALBANY, N.Y., July 12, 2021 /PRNewswire/ — Geriatrics care has made enormous strides over the past few decades. Rapidly aging populations notably in some
Worldwide Infusion Therapy Industry To 2026 – Rapid Technological Innovations Present Opportunities
DUBLIN, July 9, 2021 /PRNewswire/ — The “Infusion Therapy Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2026” report has been
Active Pharmaceutical Ingredients Market Worth USD 312 Billion by 2028 at 6.2% CAGR – Report by Market Research Future (MRFR)
Active Pharmaceutical Ingredients Market Insights and Industry Analysis by Type of Synthesis (Biotech and Synthetic), By Molecules (Large Molecule and…
Mirikizumab Up-Regulates Genes Associated with Mucosal Healing in Ulcerative Colitis for Up to One Year in Phase 2 Study
INDIANAPOLIS, July 9, 2021 /PRNewswire/ — Eli Lilly and Company (NYSE: LLY) announced new Phase 2 data showing that gene expression changes induc…
CIO Leadership: Embracing Resilient Leadership to Confidently Navigate Today's Demanding Business Environment Will Drive the Discussion at HMG Strategy's First In-Person Event for 2021 in Atlanta on A
WESTPORT, Conn., July 08, 2021 — HMG Strategy, the World’s #1 digital platform for enabling technology executives to reimagine the enterprise and reshape the business world, is…
Forget a Bear Market — These 2 Nasdaq Stocks Are Moving Higher
Even with markets suffering, there were still some positives on Wall Street.
Forget Senseonics, Buy These 3 Diabetes Stocks Instead By StockNews
Forget Senseonics, Buy These 3 Diabetes Stocks Instead
Verge Genomics : Announces Three-Year Collaboration With Lilly to Discover and Develop Novel Treatments Using Its AI-Driven All-in-Human Platform
– Verge to Receive Up to $25M in Upfront, Equity Investment and Potential Near-Term Payments, with Additional Milestone Value of $694M and Potential Downstream Royalties – Collaboration to Advance…
Bajaj Healthcare surges 11% on receiving DRDO nod to manufacture 2-DG
Read more about Bajaj Healthcare surges 11% on receiving DRDO nod to manufacture 2-DG on Business Standard. The company has received a licence from DRDO to manufacture and market “2-Deoxy-D-Glucose” (2-DG) as approved medication for the treatment of COVID-19 patients
Here's Why Biohaven Pharmaceutical Is Soaring Today
Preliminary sales figures for the company's new migraine drug were much better than expected.
Global Anticoagulants Market (2021 to 2026) – by Drug Class, Route of Administration and Geography
DUBLIN, July 7, 2021 /PRNewswire/ — The 'Global Anticoagulants Market (2021-2026) by Drug Class, Route of Administration, Geography and the Impac…
The Worldwide Precision Medicine Industry is Expected to Reach $738.8 Billion by 2030
DUBLIN, July 7, 2021 /PRNewswire/ — The 'Precision Medicine Market Research Report: By Type (Therapeutics, Diagnostics, Personalized Medical Care…
10 Psychedelic Startups Investors are Flocking To
In this article, we discuss the 10 psychedelic startups investors are flocking to. If you want to skip our detailed analysis of these startups, go directly…
Breakthrough results for empagliflozin confirm EMPEROR-Preserved as first and only successful trial for heart failure with preserved ejection fraction
– The EMPEROR-Preserved Phase III trial met its primary endpoint and demonstrated significant risk reduction with empagliflozin for the composite of cardiovascular death or hospitalization for…
Sitryx licenses intellectual property rights for inhibitors of a new target in immunometabolism from Cancer Research UK in exclusive worldwide agreement
Sitryx licenses intellectual property rights for inhibitors of a new target in immunometabolism from Cancer Research UK in exclusive worldwide agreement Oxford, UK – 6 July 2021…
Eli Lilly (LLY) Reported Weak Q1 Results
Eli Lilly and Co. (NYSE:LLY) was founded by a pharmacist named Colonel Eli Lilly way back in 1876. The company, known for its quality drugs, is often…
Biotech Ingredients Market to Garner $75.3 Billion, Globally, By 2028 at 4.8% CAGR, Says Allied Market Research
– Increase in consumer preference from synthetic to bio-based ingredients and development in biotechnology fuel the growth of the global biotech i…
Biotech Ingredients Market to Garner $75.3 Billion, Globally, By 2028 at 4.8% CAGR, Says Allied Market Research
PORTLAND, Ore., July 5, 2021 /PRNewswire/ — Allied Market Research published a report, titled, 'Biotech Ingredients Market by Type (Active Pharma…
Eli Lilly and Company (LLY) Special Call – Slideshow (NYSE:LLY)
The following slide deck was published by Eli Lilly and Company in conjunction with this event.
Dicerna Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Dicerna Pharmaceuticals, Inc. (Nasdaq: DRNA) (the “Company” or “Dicerna”), a leading developer of investigational ribonucleic acid interference (RNAi)